midazolam has been researched along with nitrazepam in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bredesen, JE; Lunde, PK; Matheson, I | 1 |
| Feely, M; Garratt, JC; Gent, JP; Haigh, JR | 1 |
| Bredesen, JE; Godtilbsen, OB; Gordeladze, JO; Jerkø, D; Matheson, I | 1 |
| Allen, JG; Altman, J; Castleden, CM; St John-Smith, P | 1 |
| Breimer, DD; Jochemsen, R | 1 |
| Cruz, AP; Frei, F; Graeff, FG | 1 |
| Brinkman, UA; Herráez-Hernández, R; Louter, AJ; van de Merbel, NC | 1 |
| Baker, AB; Ballantyne, JA; Kumar, K | 1 |
| Bagherian, GA; Chamjangali, MA; Farsimadan, S; Goudarzi, N | 1 |
3 trial(s) available for midazolam and nitrazepam
| Article | Year |
|---|---|
Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects.
Topics: Adult; Blood Proteins; Double-Blind Method; Female; Humans; Hydrogen-Ion Concentration; Midazolam; Milk, Human; Nitrazepam; Time Factors; Triglycerides | 1990 |
Residual effect of single and repeated doses of midazolam and nitrazepam in relation to their plasma concentrations.
Topics: Adult; Benzodiazepines; Female; Humans; Male; Memory; Midazolam; Nitrazepam; Perception; Psychomotor Performance; Sleep | 1986 |
A comparison of oral midazolam, nitrazepam and placebo in young and elderly subjects.
Topics: Adult; Aged; Aged, 80 and over; Electroencephalography; Female; Humans; Hypnotics and Sedatives; Kinetics; Male; Midazolam; Nitrazepam; Psychomotor Performance | 1987 |
17 other study(ies) available for midazolam and nitrazepam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential?
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Chlordiazepoxide; Drug Tolerance; Male; Mice; Midazolam; Nitrazepam; Pentylenetetrazole | 1988 |
Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Bromazepam; Child; Clobazam; Flunitrazepam; Flurazepam; Humans; Hydroxylation; Kinetics; Lorazepam; Midazolam; Middle Aged; Nitrazepam; Nordazepam | 1984 |
Ethopharmacological analysis of rat behavior on the elevated plus-maze.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Behavior, Animal; Carbolines; Exploratory Behavior; GABA-A Receptor Agonists; Male; Midazolam; Motor Activity; Nitrazepam; Pentylenetetrazole; Rats; Rats, Wistar | 1994 |
Automated on-line dialysis for sample preparation for gas chromatography: determination of benzodiazepines in human plasma.
Topics: Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Chromatography, Gas; Dialysis; Diazepam; Humans; In Vitro Techniques; Medazepam; Midazolam; Nitrazepam | 1996 |
Determination of droperidol in plasma by liquid chromatography.
Topics: Adjuvants, Anesthesia; Chromatography, High Pressure Liquid; Droperidol; Flurazepam; Half-Life; Heart Valve Diseases; Humans; Midazolam; Myocardial Revascularization; Nitrazepam | 1996 |
Optimization of modified dispersive liquid-liquid microextraction coupled with high-performance liquid chromatography for the simultaneous preconcentration and determination of nitrazepam and midazolam drugs: An experimental design.
Topics: Chromatography, High Pressure Liquid; Humans; Hypnotics and Sedatives; Liquid Phase Microextraction; Midazolam; Nitrazepam | 2015 |